ESC 365 - The value of NT-proBNP in Cardiovascular Risk Stratification and Optimization of Cardioprotective Treatment among Patients with Type 2 Diabetes.

Open Access

The value of NT-proBNP in Cardiovascular Risk Stratification and Optimization of Cardioprotective Treatment among Patients with Type 2 Diabetes.

Session: The value of NT-proBNP in Cardiovascular Risk Stratification and Optimization of Cardioprotective Treatment among Patients with Type 2 Diabetes

Topic: Chronic Heart Failure

Speaker: Doctor M. Vaduganathan (Boston, Massachusetts, US) Doctor A. Bayes Genis (Badalona, ES)

Sponsored by Roche Diagnostics International

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speakers

Doctor Muthiah Vaduganathan

Brigham and Women?s Hospital and Harvard Medical School, Boston, Massachusetts (United States of America)

4 presentations

1 follower

Doctor Antonio Bayes Genis

University Hospital Germans Trias and Pujol de Badalona, Badalona (Spain)

41 presentations

8 followers

1 more presentation in this session

Q&A.

Access the full session

The value of NT-proBNP in Cardiovascular Risk Stratification and Optimization of Cardioprotective Treatment among Patients with Type 2 Diabetes

Speakers: Doctor M. Vaduganathan, Doctor A. Bayes Genis

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by